Taken together, the presence of CD45+ CTCs were demonstrated in patients bearing various cancer types (CRC, NSCLC and HCC) and they were significantly associated with more extensive metastasis and poor prognosis. This evidence concerns the gene PTPRC and colorectal carcinoma.